I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Spurgeon, Stephen E.
293
results:
Articles (Online) X
Search for persons
X
Languages
english (283)
german (1)
Sorted by: Relevance
Sorted by: Year
?
1
Diminished humoral and cellular responses to SARS-CoV-2 vac..:
Ujjani, Chaitra
;
Gooley, Ted A.
;
Spurgeon, Stephen E.
...
Blood Advances. 7 (2023) 17 - p. 4728-4737 , 2023
Link:
https://doi.org/10.1182/..
?
2
Cellular and humoral immune response to mRNA COVID-19 vacci..:
Lyski, Zoe L.
;
Kim, Myung S.
;
Xthona Lee, David
...
Blood Advances. 6 (2022) 4 - p. 1207-1211 , 2022
Link:
https://doi.org/10.1182/..
?
3
Combined epigenetic and immunotherapy for blastic and class..:
LeBlanc, Francis R.
;
Hasanali, Zainul S.
;
Stuart, August
...
Oncotarget. 13 (2022) 1 - p. 986-1002 , 2022
Link:
https://doi.org/10.18632..
?
4
A phase II study of obinutuzumab in combination with ibruti..:
Kim, Myung Sun
;
Banerjee, Titas
;
Chen, Andy
...
Leukemia & Lymphoma. 64 (2022) 3 - p. 722-724 , 2022
Link:
https://doi.org/10.1080/..
?
5
Phase 1/2 study of acalabrutinib and the PI3K delta inhibit..:
Barr, Paul M.
;
Smith, Stephen D.
;
Roschewski, Mark J.
...
Leukemia & Lymphoma. 63 (2022) 7 - p. 1728-1732 , 2022
Link:
https://doi.org/10.1080/..
?
6
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed..:
Lyski, Zoe L.
;
Kim, Myung Sun
;
Xthona Lee, David
...
Case Reports in Hematology. 2022 (2022) - p. 1-5 , 2022
Link:
https://doi.org/10.1155/..
?
7
A phase Ib, open label, dose escalation trial of the anti-C..:
Danilov, Alexey V.
;
Spurgeon, Stephen E.
;
Siddiqi, Tanya
...
Investigational New Drugs. 39 (2021) 4 - p. 1099-1105 , 2021
Link:
https://doi.org/10.1007/..
?
8
Proapoptotic and immunomodulatory effects of SYK inhibitor ..:
Lam, Vi
;
Best, Scott
;
Kittai, Adam
...
British Journal of Clinical Pharmacology. 88 (2021) 2 - p. 836-841 , 2021
Link:
https://doi.org/10.1111/..
?
9
Entospletinib and obinutuzumab in patients with relapsed/re..:
Kittai, Adam S.
;
Best, Scott
;
Thurlow, Bria
...
Haematologica. 106 (2021) 7 - p. 2022-2025 , 2021
Link:
https://doi.org/10.3324/..
?
10
The First Report of Endoscopic Ultrasound-guided Intralesio..:
Fay, Emily
;
Herzig, Daniel
;
Sharzehi, Kaveh
.
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) 8 - p. e485-e487 , 2020
Link:
https://doi.org/10.1016/..
?
11
A novel somatic PLCG2 variant associated with resistance to..:
Raghunathan, Vikram
;
Fan, Guang
;
Kittai, Adam S.
...
European Journal of Haematology. 106 (2020) 2 - p. 294-297 , 2020
Link:
https://doi.org/10.1111/..
?
12
Phase 1–2 study of vorinostat (SAHA), cladribine and rituxi..:
Spurgeon, Stephen E.
;
Sharma, Kamal
;
Claxton, David F.
...
British Journal of Haematology. 186 (2019) 6 - p. 845-854 , 2019
Link:
https://doi.org/10.1111/..
?
13
Targeting of colony-stimulating factor 1 receptor (CSF1R) i..:
Edwards V, David K.
;
Sweeney, David Tyler
;
Ho, Hibery
...
Oncotarget. 9 (2018) 37 - p. 24576-24589 , 2018
Link:
https://doi.org/10.18632..
?
14
Comorbidities predict inferior outcomes in chronic lymphocy..:
Gordon, Max J.
;
Churnetski, Michael
;
Alqahtani, Hamood
...
Cancer. 124 (2018) 15 - p. 3192-3200 , 2018
Link:
https://doi.org/10.1002/..
?
15
CPX-351 exhibits potent and direct ex vivo cytotoxicity aga..:
Gordon, Max J.
;
Tardi, Paul
;
Loriaux, Marc M.
...
Leukemia Research. 53 (2017) - p. 39-49 , 2017
Link:
https://doi.org/10.1016/..
1-15